loader
Please Wait
Applying Filters...
menu
    • menu

    First Subjects Dosing with VS-041 a Novel Heart Failure Treatment services provided by Quotient Sciences

    Virtual BoothMenuQuotient Sciences
    First Subjects Dosing with VS-041 a Novel Heart Failure Treatment

    PDF Upload Sep, 2024
    News
    Quotient Sciences Advances AI-Designed Drug Product

    29 May 2026

    // PRESS RELEASE

    Quotient Sciences Extends Mfg Partnership For Ultra-Rare Disease

    27 Feb 2026

    // PRESS RELEASE

    First-in-Human Is Not Just About Safety

    09 Feb 2026

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Quotient rm 250x250

    Contact Supplier

    Website

    Annual Outsourcing in CT

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/O2qjELq5xJc
    Xls

    CATEGORY PAGE
    Menu

    Quotient Sciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PI72998
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.